Non-trough serum drug levels of adalimumab and etanercept are associated with response in patients with psoriatic arthritis.

Philippa D K CurryRyan M HumAndrew P MorrisMeghna JaniHector ChinoyAnne BartonJames Bluettnull null

Published in: Rheumatology (Oxford, England) (2023)

Higher 3-month SDL were detected in responders. Interventions to optimise SDL may improve treatment response earlier. This study suggests 3-month SDL thresholds which may be useful in clinical practice to optimise treatment response.

Keyphrases

rheumatoid arthritis
clinical practice
juvenile idiopathic arthritis
physical activity
ankylosing spondylitis
emergency department
rheumatoid arthritis patients
disease activity